SPARC (secreted protein and rich in cysteine), a matricellular protein found to be underexpressed in certain cancers, has emerged as a multifunctional protein capable of inhibiting the growth of neuroblastomas [1], leukemia [2], pancreatic [3], colorectal [4] and ovarian cancers [5]. The gene discussed is SPARC; the disease is neuroblastoma.